BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING TO GPA33 AND CD3, AND USES THEREOF

• 收藏
• 分享

专利权人:

INC.;MACROGENICS

发明人:

MACROGENICS, INC.

申请号：

GEAP2014014099

公开号：

GEP20197033B

申请日:

2014.08.20

申请国别(地区):

GE

年份:

2019

代理人:

摘要：

Present invention is directed to bi-specific diabodies which possess binding to epitope of CD3 on T-cells surface, and to epitope of GPA33 on tumor-cells surface. Said antibodies are used at the treatment of cancer related to expression GPA33.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/